These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19722062)

  • 1. Contribution of the diffusion-weighted MRI in the diagnosis and follow-up of encephalopathy caused by maple syrup urine disease in a full-term newborn.
    Ferraz-Filho JR; Floriano VH; Quirici MB; Albuquerque RP; Souza AS
    Arq Neuropsiquiatr; 2009 Sep; 67(3A):719-23. PubMed ID: 19722062
    [No Abstract]   [Full Text] [Related]  

  • 2. Age dependence of diffusion-weighted magnetic resonance imaging findings in maple syrup urine disease encephalopathy.
    Sakai M; Inoue Y; Oba H; Ishiguro A; Sekiguchi K; Tsukune Y; Mitomo M; Nakamura H
    J Comput Assist Tomogr; 2005; 29(4):524-7. PubMed ID: 16012312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease.
    Schönberger S; Schweiger B; Schwahn B; Schwarz M; Wendel U
    Mol Genet Metab; 2004 May; 82(1):69-75. PubMed ID: 15110325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maple syrup urine disease encephalopathy: a follow-up study in the acute stage using diffusion-weighted MRI.
    Ha JS; Kim TK; Eun BL; Lee HS; Lee KY; Seol HY; Cha SH
    Pediatr Radiol; 2004 Feb; 34(2):163-6. PubMed ID: 14504844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two novel compound heterozygous mutations in the BCKDHB gene that cause the intermittent form of maple syrup urine disease.
    Guo Y; Liming L; Jiang L
    Metab Brain Dis; 2015 Dec; 30(6):1395-400. PubMed ID: 26239723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI in acute intermittent maple syrup urine disease.
    Di Rocco M; Biancheri R; Rossi A; Allegri AE; Vecchi V; Tortori-Donati P
    Neurology; 2004 Sep; 63(6):1078. PubMed ID: 15452301
    [No Abstract]   [Full Text] [Related]  

  • 7. Diffusion-weighted magnetic resonance imaging in a case of severe classic maple syrup urine disease.
    Xia W; Yang W
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):805-8. PubMed ID: 25879313
    [No Abstract]   [Full Text] [Related]  

  • 8. Maple syrup urine disease: diffusion-weighted and diffusion-tensor magnetic resonance imaging findings.
    Parmar H; Sitoh YY; Ho L
    J Comput Assist Tomogr; 2004; 28(1):93-7. PubMed ID: 14716239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening for maple syrup urine disease.
    Snyderman SE; Sansaricq C
    J Pediatr; 1985 Aug; 107(2):259-61. PubMed ID: 4020551
    [No Abstract]   [Full Text] [Related]  

  • 10. Valine-toxic intermittent maple syrup urine disease: a previously unrecognized variant.
    Zipf WB; Hieber VC; Allen RJ
    Pediatrics; 1979 Feb; 63(2):286-94. PubMed ID: 440821
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maple syrup urine disease: report of a case.
    Rao GP; Ramanamurthy PS; Ghafoorunnisa ; Rafeeq MR; Pathak R
    Indian Pediatr; 1974 Aug; 11(8):585-7. PubMed ID: 4443061
    [No Abstract]   [Full Text] [Related]  

  • 13. Maple syrup urine disease: diffusion-weighted MRI findings during acute metabolic encephalopathic crisis.
    Kilicarslan R; Alkan A; Demirkol D; Toprak H; Sharifov R
    Jpn J Radiol; 2012 Jul; 30(6):522-5. PubMed ID: 22476847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India.
    Bindu PS; Shehanaz KE; Christopher R; Pal PK; Ravishankar S
    J Child Neurol; 2007 Jul; 22(7):911-3. PubMed ID: 17715290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation.
    Jan W; Zimmerman RA; Wang ZJ; Berry GT; Kaplan PB; Kaye EM
    Neuroradiology; 2003 Jun; 45(6):393-9. PubMed ID: 12736767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases.
    Cheng A; Han L; Feng Y; Li H; Yao R; Wang D; Jin B
    Diagn Interv Radiol; 2017; 23(5):398-402. PubMed ID: 28830848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging in neonatal maple syrup urine disease.
    Jain P; Sharma S; Sankhyan N; Gupta N; Kabra M; Gulati S
    Indian J Pediatr; 2013 Jan; 80(1):87-8. PubMed ID: 22865353
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduction of plasma concentrations of large neutral amino acids in patients with maple syrup urine disease during crises.
    Wajner M; Vargas CR
    Arch Dis Child; 1999 Jun; 80(6):579. PubMed ID: 10523253
    [No Abstract]   [Full Text] [Related]  

  • 19. Imaging in Maple Syrup Urine Disease.
    Shah T; Purohit S; Raval M
    Indian J Pediatr; 2018 Oct; 85(10):927-928. PubMed ID: 29744745
    [No Abstract]   [Full Text] [Related]  

  • 20. Teaching NeuroImages: MRI in maple syrup urine disease.
    Bindu PS; Kovoor JM; Christopher R
    Neurology; 2010 Jan; 74(3):e12. PubMed ID: 20083792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.